首页>
外国专利>
RNF41 AS A BIOMARKER PREDICTING RESPONSE TO LENALIDOMIDE IN NON-DEL(5Q) MDS
RNF41 AS A BIOMARKER PREDICTING RESPONSE TO LENALIDOMIDE IN NON-DEL(5Q) MDS
展开▼
机译:RNF41作为非DEL(5Q)MDS中对来那度胺的生物标记预测
展开▼
页面导航
摘要
著录项
相似文献
摘要
Disclosed herein is a method of using erythroid expression levels of RNF41 as a predictive biomarker for responsiveness to lenalidomide (LEN) in patients with non-del(5q) MDS.
展开▼